Protocol ID93-008 
Page 3 of 5 
I have been given an opportunity to ask any questions concerning 
the procedure involved and the investigator has been willing to 
reply to my inquiries. This procedure will be administered under 
the above numbered, title, and described clinical research protocol 
at this institution. I hereby authorize Dr. Ralph S. Freedman the 
attending physician /investigator and designated associates, to 
administer this procedure. 
1 have been told and understand that my participation in this 
clinical research study is voluntary. I may decide not to 
participate, or withdraw my consent and discontinue my 
participation at any time. Such action will be without prejudice 
and there shall be no penalty or loss of benefits to which I may 
otherwise be entitled, and I will continue to receive treatment by 
my physician at this institution. 
Should I decide not to participate or withdraw my consent from 
participation in this clinical research, I have been advised that I 
should discuss the consequences or effects of my decision with my 
physician. 
In addition, I understand that the investigator may discontinue the 
clinical research study if, in the sole opinion and discretion of the 
investigator, the study or treatment offers me little or no future 
benefit, or the supply of medication ceases to be available or other 
causes prevent continuation of the clinical research study. The 
investigator will notify me should such circumstances arise and my 
physician will advise me about available treatments which may be 
of benefit at that time. 
I will be informed of any new findings developed during the course 
of this cUnical research study which may relate to my willingness 
to continue participation in this study. 
I have been assured that confidentiality will be preserved except 
that qualified monitors from the National Cancer Institute, Food 
and Drug Administration, and Genetics Therapy Incorporated, and 
Applied Immune Sciences. Inc., may review my records where 
appropriate and necessary. Qualified monitors shall include 
assignees authorized by the Surveillance Committee of this 
institution provided that confidentiality is assured and preserved. 
My name will not be revealed in any reports or publications 
resulting from this study, without my expressed consent. 
1 have been informed that should I suffer any injuiy as a result of 
participation in this research activity, reasonable medical facilities 
are available for treatment at this institution. I understand, 
however, that 1 cannot expect to receive any credit or 
Recombinant DNA Research, Volume 19 
